Spinraza
1 known investors
Find your way into Spinraza
Sign up to see every warm intro you have to Spinraza
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spinraza team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SPINRAZA is a prescription treatment for spinal muscular atrophy (SMA) that is delivered directly into the cerebrospinal fluid around the spinal cord to reach target tissues. It is aimed at patients diagnosed with SMA and has been studied in an extended clinical trial program.
Investors · 1
Frequently asked questions
- What does Spinraza do?
- SPINRAZA is a prescription treatment for spinal muscular atrophy (SMA) that is delivered directly into the cerebrospinal fluid around the spinal cord to reach target tissues. It is aimed at patients diagnosed with SMA and has been studied in an extended clinical trial program.
- Who are Spinraza's investors?
- Spinraza's investors include DRI Healthcare.